Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Advanced Neoplasm”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT00747734
What this trial is testing

MNRP1685A in Patients With Locally Advanced or Metastatic Solid Tumors

Who this might be right for
Solid Cancers
Genentech, Inc. 35
Very early researchUnknownNCT04074564
What this trial is testing

MASCT-I Combined With Apatinib and/or Camrelizumab in the Treatment of Bone and Soft Tissue Sarcoma

Who this might be right for
Sarcoma
HRYZ Biotech Co. 60
Early research (Phase 1)Study completedNCT04937153
What this trial is testing

GEN1046 Safety and PK in Subjects With Advanced Solid Malignancies

Who this might be right for
Solid Tumor
Genmab 18
Testing effectiveness (Phase 2)Study completedNCT04570839
What this trial is testing

COM701 in Combination With BMS-986207 and Nivolumab in Subjects With Advanced Solid Tumors.

Who this might be right for
Endometrial NeoplasmsOvarian CancerSolid Tumor+1 more
Compugen Ltd 48
Early research (Phase 1)Looking for participantsNCT04842812
What this trial is testing

Engineered TILs/CAR-TILs to Treat Advanced Solid Tumors

Who this might be right for
Liver CancerLung CancerBreast Cancer+5 more
Second Affiliated Hospital of Guangzhou Medical University 40
Early research (Phase 1)Ended earlyNCT02244112
What this trial is testing

Oprozomib to Assess Food Effect, Drug-Drug Interaction With Midazolam, and Safety and Tolerability in Patients With Advanced Malignancies

Who this might be right for
Advanced Non-Central Nervous System (CNS) Malignancies
Amgen 43
Testing effectiveness (Phase 2)UnknownNCT04380012
What this trial is testing

A Clinical Study of Pyrotinib in Patients With HER2-positive Advanced Colorectal Cancer

Who this might be right for
Colorectal Cancer
Second Affiliated Hospital, Zhejiang University, School of Medicine 40
Early research (Phase 1)Study completedNCT01324492
What this trial is testing

Safety and Efficacy of RAD001 in Chinese Patients With Advanced Pulmonary Neuroendocrine Tumor

Who this might be right for
Lung Neuroendocrine Neoplasm
Novartis Pharmaceuticals 16
Early research (Phase 1)Not Yet RecruitingNCT07650357
What this trial is testing

CLSP 5282 in HLA-A*03:01 Positive Adult Patients With Solid Tumors (SENTINEL-101)

Who this might be right for
Advanced Solid TumorNon Small Cell Lung CancerPancreatic Carcinoma+1 more
Clasp Therapeutics, Inc. 140
Early research (Phase 1)Study completedNCT00201812
What this trial is testing

Phase I & Biological Study of Etanercept & Weekly Docetaxel in Patients With Advanced Solid Tumors

Who this might be right for
Tumors
Ohio State University Comprehensive Cancer Center 27
Not applicableUnknownNCT02069067
What this trial is testing

Observational Study of Incidence of Breakthrough Cancer Pain and How it is Treated

Who this might be right for
Advanced Cancer
National Cancer Institute, Naples 500
Large-scale testing (Phase 3)Study completedNCT03856411
What this trial is testing

Evaluate the Efficacy and Safety of Toripalimab or Placebo Combined With Chemotherapy in Treatment-naive Advanced NSCLC

Who this might be right for
Treatment-naive Advanced Non-small Cell Lung Cancer
Shanghai Junshi Bioscience Co., Ltd. 465
Early research (Phase 1)UnknownNCT04906044
What this trial is testing

Total Neoadjuvant Treatment Plus PD-1 in Mid-Low Locally Advanced Rectal Cancer

Who this might be right for
TislelizumabLocally Advanced Rectal CancerTotal Neoadjuvant Treatment+1 more
The First Hospital of Jilin University 46
Testing effectiveness (Phase 2)Enrolling By InvitationNCT06768268
What this trial is testing

A Dose-Image Optimization Trial Evaluating Mannitol and Voluven as Adjuncts for Indocyanine Green

Who this might be right for
Breast Cancer Early Stage Breast Cancer (Stage 1-3)
National Taiwan University Hospital 30
Testing effectiveness (Phase 2)WithdrawnNCT02747797
What this trial is testing

Lucitanib (E3810) in Patients With Advanced Cancer and FGFR, VEGFR, or PDGFR Pathway Aberrations

Who this might be right for
Advanced Cancer
Teresa Helsten, MD
Early research (Phase 1)WithdrawnNCT00997360
What this trial is testing

Study of PKI-179 Administered Orally to Subjects With Solid Tumors

Who this might be right for
Advanced Malignant Solid Tumors
Wyeth is now a wholly owned subsidiary of Pfizer
Early research (Phase 1)Study completedNCT01287520
What this trial is testing

LY2090314 in Patients With Advanced or Metastatic Cancer

Who this might be right for
Advanced Cancer
Eli Lilly and Company 41
Not applicableUnknownNCT06205823
What this trial is testing

Compare Clinical Outcomes Between Advanced Immunotherapy and Classical Immunochemotherapy in RRMM

Who this might be right for
Myeloma Multiple
Seoul St. Mary's Hospital 1,600
Early research (Phase 1)Study completedNCT01139788
What this trial is testing

LY2624587 in Patients With Advanced Cancer

Who this might be right for
Metastatic Cancer
Eli Lilly and Company 56
Testing effectiveness (Phase 2)UnknownNCT05044988
What this trial is testing

HS-10342 in Chinese Patients With HR+/HER2- Advanced and/or Metastatic Breast Cancer

Who this might be right for
HR+/HER2- Advanced and/or Metastatic Breast Cancer
Jiangsu Hansoh Pharmaceutical Co., Ltd. 20
Next Page